Nordic Nanovector to present at DNB’s SME conference and Kempen Life Science conference

On March 28, 2019 Nordic Nanovector ASA (OSE: NANO) reported that members of its senior management team will participate and present at the following upcoming investor conferences during April (Press release, Nordic Nanovector, MAR 28, 2019, View Source [SID1234553454]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

DNB’s 15th Annual Small & Medium Enterprises (SME) Conference in Oslo on 4 April
The 12th Kempen Life Sciences Conference in Amsterdam on 16-17 April
The company presentation will be available on the investors and media page on the first day of the conference.

For further information, please contact:

IR enquiries

Malene Brondberg, VP Investor Relations and Corporate Communications

Cell: +44 7561 431 762

Email: [email protected]

Media Enquiries

Mark Swallow/David Dible (Citigate Dewe Rogerson)

Tel: +44 207 638 9571

Email: [email protected]